Could statins constitute a novel treatment for endometriosis? Systematic review of the literature

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2014
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, v.179, p.153-158, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Endometriosis, defined as the presence of endometrial glands and/or stroma outside the uterine cavity, is an estrogen-dependent disease that affects about 10% of reproductive age women. Theories to explain the etiology of endometriosis abound. These include the alteration of epithelial cells on peritoneal surface, metaplasia of embryonic remnants of the mullerian ducts, immune system abnormalities, and the dissemination of endometrial cells through the circulation or lymphatic system, as well as retrograde menstruation, the hypothesis currently favored for the development of endometriosis. Angiogenesis, the development of new capillaries from pre-existing blood vessels, has been proposed as a key mechanism in the pathogenesis of endometriosis. Again from an etiological perspective, the formation of endometriotic implants requires ectopic fixation and proliferation of endometrial stroma and glands. The process of invasive insertion of endometriotic tissues involves the degradation of the extracellular matrix, and altered expression of matrix metalloproteinases (MMPs) in the eutopic and ectopic endometrium. Considering the antiproliferative, antiangiogenic, antioxidant, anti-inflammatory properties and matrix metalloproteinase activity inhibition of statins and the original studies addressing the possible mechanisms of action in endometriosis, the aim of this systematic review was to synthesize the research conducted to date in order to propose statins as possible and effective tools for controlling this disease.
Palavras-chave
Endometriosis, Statins
Referências
  1. Almassinokiani F, 2013, MED SCI MONITOR, V19, P534, DOI 10.12659/MSM.883967
  2. Anaf V, 2000, HUM REPROD, V15, P767, DOI 10.1093/humrep/15.4.767
  3. Bang Casper N, 2014, Curr Cardiol Rep, V16, P461, DOI 10.1007/s11886-013-0461-4
  4. Bohm M, 2004, Z KARDIOL, V93, P43, DOI 10.1007/s00392-004-1003-2
  5. Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
  6. Bruner-Tran KL, 2009, J CLIN ENDOCR METAB, V94, P2489, DOI 10.1210/jc.2008-2802
  7. Bruner-Tran KL, 2011, BIOL REPROD, V84, P106, DOI 10.1095/biolreprod.110.086744
  8. Cakmak H, 2012, REPROD SCI, V19, P572, DOI 10.1177/1933719111430998
  9. Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf
  10. Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
  11. Chan KKW, 2003, CLIN CANCER RES, V9, P10
  12. Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235
  13. Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003
  14. Deng P, 2006, CLIN CHEM, V52, P300, DOI 10.1373/clinchem.2005.057893
  15. Esfandiari N, 2007, FERTIL STERIL, V87, P257, DOI 10.1016/j.fertnstert.2006.06.040
  16. GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
  17. Hsieh CY, 2008, CLIN THER, V30, P1330, DOI 10.1016/j.clinthera.2008.07.010
  18. Koh KK, 2013, INT J CARDIOL, V166, P509, DOI 10.1016/j.ijcard.2011.11.028
  19. Mahajan N, 2010, INT J CARDIOL, V142, P273, DOI 10.1016/j.ijcard.2009.01.008
  20. Mancini GBJ, 2013, CAN J CARDIOL, V29, P1553, DOI 10.1016/j.cjca.2013.09.023
  21. Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714
  22. Manzoni M, 2002, APPL MICROBIOL BIOT, V58, P555, DOI 10.1007/s00253-002-0932-9
  23. Moon H, 2014, TRENDS ENDOCRIN MET, V25, P188, DOI 10.1016/j.tem.2013.12.007
  24. Nasu K, 2009, FERTIL STERIL, V92, P2097, DOI 10.1016/j.fertnstert.2009.06.055
  25. Oktem M, 2007, HUM REPROD, V22, P1474, DOI 10.1093/humrep/del505
  26. Petta CA, 2009, EUR J OBSTET GYN R B, V143, P128, DOI 10.1016/j.ejogrb.2008.12.012
  27. Piotrowski PC, 2006, BIOL REPROD, V75, P107, DOI 10.1095/biolreprod.106.051763
  28. Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516
  29. Podgaec S, 2012, AM J REPROD IMMUNOL, V68, P301, DOI 10.1111/j.1600-0897.2012.01173.x
  30. Rutishauser J, 2006, SWISS MED WKLY, V136, P41
  31. Sharma I, 2010, FERTIL STERIL, V94, P1639, DOI 10.1016/j.fertnstert.2009.10.003
  32. Sidell N, 2010, MOL ENDOCRINOL, V24, P148, DOI 10.1210/me.2009-0155
  33. Sokalska A, 2013, J CLIN ENDOCR METAB, V98, pE463, DOI 10.1210/jc.2012-3402
  34. Sokalska A, 2012, BIOL REPROD, V87, P1
  35. Sokalska A, 2010, J CLIN ENDOCR METAB, V95, P3453, DOI 10.1210/jc.2010-0072
  36. Stankovic I, 2010, CLIN THER, V32, P909, DOI 10.1016/j.clinthera.2010.04.017
  37. STOVALL DW, 1992, FERTIL STERIL, V57, P984
  38. Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007
  39. Villanueva JA, 2013, J CLIN ENDOCR METAB, V98, pE455, DOI 10.1210/jc.2012-3387
  40. Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393
  41. Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X
  42. Wilson WRW, 2005, EUR J VASC ENDOVASC, V30, P259, DOI 10.1016/j.ejvs.2005.02.044
  43. Yilmaz B, 2010, REPROD BIOMED ONLINE, V20, P291, DOI 10.1016/j.rbmo.2009.11.004
  44. Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325
  45. Zhong WB, 2005, ENDOCR-RELAT CANCER, V12, P615, DOI 10.1677/erc.1.01012